Evidence map›Paper›PMID 27919225›Full record

ArticleBMC infectious diseases2016

Comparison of the first three waves of avian influenza A(H7N9) virus circulation in the mainland of the People's Republic of China.

Nijuan Xiang, A Danielle Iuliano, Yanping Zhang, Ruiqi Ren, Xingyi Geng, Bili Ye, Wenxiao Tu, Ch Ao Li, Yong Lv, Ming Yang and 9 more

Abstract readComparative Study
In one paragraph

Article in BMC infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Novel influenza A viruses and pandemic threats.Lancet (London, England) · 2017
    Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Nijuan XiangChinese Center for Disease Control and Prevention, No. 155 Changbai Road, Changping District, Beijing, China.
A Danielle IulianoUS Centers for Disease Control and Prevention, Atlanta, GA, USA.
Yanping ZhangChinese Center for Disease Control and Prevention, No. 155 Changbai Road, Changping District, Beijing, China.
Ruiqi RenChinese Center for Disease Control and Prevention, No. 155 Changbai Road, Changping District, Beijing, China.
Xingyi GengJinan Prefecture Center for Disease Control and Prevention, Shandong, China.
Bili YeShenzhen Prefecture Center for Disease Control and Prevention, Guangdong, China.
Wenxiao TuChinese Center for Disease Control and Prevention, No. 155 Changbai Road, Changping District, Beijing, China.
Ch Ao LiTianjin Municipal Center for Disease Control and Prevention, Tianjin, China.
Yong LvLuan Prefecture Center for Disease Control and Prevention, Anhui, China.
Ming YangXuancheng Prefecture Center for Disease Control and Prevention, Anhui, China.
Jian ZhaoChinese Center for Disease Control and Prevention, No. 155 Changbai Road, Changping District, Beijing, China.
Yali WangChinese Center for Disease Control and Prevention, No. 155 Changbai Road, Changping District, Beijing, China.
Fuqiang YangJiangxi Provincial Center for Disease Control and Prevention, Jiangxi, China.
Lei ZhouChinese Center for Disease Control and Prevention, No. 155 Changbai Road, Changping District, Beijing, China.
Bo LiuChinese Center for Disease Control and Prevention, No. 155 Changbai Road, Changping District, Beijing, China.
Yuelong ShuInstitute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Daxin NiChinese Center for Disease Control and Prevention, No. 155 Changbai Road, Changping District, Beijing, China.
Zijian FengChinese Center for Disease Control and Prevention, No. 155 Changbai Road, Changping District, Beijing, China.
Qun LiChinese Center for Disease Control and Prevention, No. 155 Changbai Road, Changping District, Beijing, China. liqun@chinacdc.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundH7N9 human cases were first detected in mainland China in March 2013. Circulation of this virus has continued each year shifting to typical winter months. We compared the clinical and epidemiologic characteristics for the first three waves of virus circulation.

methodsThe first wave was defined as reported cases with onset dates between March 31-September 30, 2013, the second wave was defined as October 1, 2013-September 30, 2014 and the third wave was defined as October 1, 2014-September 30, 2015. We used simple descriptive statistics to compare characteristics of the three distinct waves of virus circulation.

resultsIn mainland China, 134 cases, 306 cases and 219 cases were detected and reported in first three waves, respectively. The median age of cases was statistically significantly older in the first wave (61 years vs. 56 years, 56 years, p < 0.001) compared to the following two waves. Most reported cases were among men in all three waves. There was no statistically significant difference between case fatality proportions (33, 42 and 45%, respectively, p = 0.08). There were no significant statistical differences for time from illness onset to first seeking healthcare, hospitalization, lab confirmation, initiation antiviral treatment and death between the three waves. A similar percentage of cases in all waves reported exposure to poultry or live poultry markets (87%, 88%, 90%, respectively). There was no statistically significant difference in the occurrence of severe disease between the each of the first three waves of virus circulation. Twenty-one clusters were reported during these three waves (4, 11 and 6 clusters, respectively), of which, 14 were considered to be possible human-to-human transmission.

conclusionThough our case investigation for the first three waves found few differences between the epidemiologic and clinical characteristics, there is continued international concern about the pandemic potential of this virus. Since the virus continues to circulate, causes more severe disease, has the ability to mutate and become transmissible from human-to-human, and there is limited natural protection from infection in communities, it is critical that surveillance systems in China and elsewhere are alert to the influenza H7N9 virus.

Indexed as

AdolescentAdultAgedAged, 80 and overAge DistributionChildChild, PreschoolChinaFemaleHospitalizationHumansInfluenza A Virus, H7N9 SubtypeInfluenza, HumanMaleMiddle AgedPandemicsAvian influenzaChinaH7N9Pandemic

Identifiers

PMID27919225
PMCPMC5139097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.